Sanovas is led by an experienced team of medical device executives. This team has launched hundreds of medical devices and has deep roots in visualization and interventional technologies.
Larry Gerrans -Chairman
Co-founder, President, and CEO of Sanovas, currently leading the next generation of interventional pulmonary science.
Pioneered the Endo-Suite and Digital Operating Room technologies for Stryker and Smith & Nephew, grew this new technology sector into a multi-national, multi-billion dollar healthcare construction enterprise that has re-invented operating rooms worldwide.
Among the first medical industry personnel to enter the Los Alamos National Laboratory to evaluate various technologies for transfer to private industry.
Total Joint Replacement Specialist for Depuy Orthopedics at Johnson & Johnson.
Advisory Board member for the Advanced Medical Technology Association's (AdvaMed) Emerging Growth Companies Council
Advisory Board member for Frost & Sullivan's 2013 Medical Device Program.
Ken Koen -Director
Founder & V.P. of Operations at AdvancedCath Technologies, Inc.
Vice President of Infinity Extrusion, responsible for managing the company’s rapidly growing extrusion business
VP of Operations at AdvancedCath Technologies, Inc. in Santa Clara, CA.
Started career at C.R. Bard (Billerica, MA) in 1988 as a laser technician.
Rob Georges -Director
Vice President, R&D Technology Integration at Maxim Integrated.
Executive positions at Signal Processing Technologies and Intersil.
Oregon Institute of Technology, B.S. in Electronics.
Bruce A. Nichols -Director
Vice President and General Manager of Vention Medical Advanced Components.
Founder and President/CEO of RiverTech Medical (in 2007) - which was then sold to Vention Medical in 2013.
Principal of Enanti Resource Group, a Medical Device Sales, Marketing, Engineering, Consulting firm.
Vice President Sales & Marketing for MedSource Technologies and HV Technologies, Inc.
Santa Clara University. M.B.A.
California State University, Fresno, B.S. Industrial Engineering.
FDA REGULATORY DISCLOSURE: Sanovas Inc. is an emerging technology company. These products are investigational medical devices that have not been approved or cleared for use in the United States.